Skip to main content
. 2019 Nov 26;11:9939–9950. doi: 10.2147/CMAR.S224532

Figure 4.

Figure 4

Kaplan–Meier curves of overall survival in 152 patients with advanced primary hepatocellular carcinoma with sorafenib duration of no less than 12 months or less than 12 months.